Finn Drabløs Selected Research

Finn Drabløs Research Topics

10	Neoplasms (Cancer) 06/2022 - 11/2004
6	Prostatic Neoplasms (Prostate Cancer) 06/2022 - 02/2017
2	Urinary Bladder Neoplasms (Bladder Cancer) 03/2015 - 01/2014
1	Endometrial Neoplasms (Endometrial Cancer) 01/2020
1	7 Hereditary Prostate Cancer 10/2017
1	Hypersensitivity (Allergy) 11/2016
1	Necrosis 01/2016
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2016
1	Non-Muscle Invasive Bladder Neoplasms 03/2015
1	Pathologic Processes 01/2015
1	Genomic Instability 01/2015
1	Autoimmune Diseases (Autoimmune Disease) 07/2013
1	Human Influenza (Influenza) 08/2010

3	Citric Acid (Citrate)FDA LinkGeneric 06/2022 - 02/2017
3	SpermineIBA 06/2022 - 02/2017
3	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 01/2015
3	Proteins (Proteins, Gene)FDA Link 06/2015 - 08/2010
2	Transcription Factors (Transcription Factor)IBA 11/2016 - 01/2015
2	Therapeutic UsesIBA 01/2016 - 03/2015
1	MetallothioneinIBA 06/2022
1	ZincIBA 06/2022
1	RNA (Ribonucleic Acid)IBA 10/2021
1	CholesterolIBA 01/2018
1	WD repeat containing planar cell polarity effectorIBA 10/2017
1	Biomarkers (Surrogate Marker)IBA 10/2017
1	Deoxyribonuclease I (Nickase)IBA 11/2016
1	AntibodiesIBA 01/2016
1	Adalimumab (Humira)FDA Link 01/2016
1	Complex MixturesIBA 01/2016
1	chlorinIBA 03/2015
1	Photosensitizing Agents (Photosensitizers)IBA 03/2015
1	EnzymesIBA 01/2015
1	Histones (Histone)IBA 01/2015
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2014
1	hydroxide ionIBA 07/2013
1	25-hydroxyvitamin DIBA 07/2013
1	Calcitriol Receptors (Calcitriol Receptor)IBA 07/2013
1	hemagglutinin esteraseIBA 08/2010
1	Chlorambucil (Leukeran)FDA Link 11/2004
1	Carmustine (FIVB)FDA Link 11/2004
1	Alkylating AgentsIBA 11/2004

1	Aftercare (After-Treatment) 01/2016
1	Therapeutics 07/2006